This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08263/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB08263/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08263/identifier/pubchem-compound/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08263/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08263/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08263
rdf:type
n3:Drug
n3:description
N-(carboxycarbonyl)-D-phenylalanine is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. It targets the protein hypoxia-inducible factor 1-alpha inhibitor.
n3:group
experimental
owl:sameAs
n13:DB08263 n14:DB08263
dcterms:title
N-(carboxycarbonyl)-D-phenylalanine
adms:identifier
n6:DB08263 n7:NDF n8:4451055 n9:5288998 n10:99444734
n3:IUPAC-Name
n4:271B472A-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4730-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B472F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B472C-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B472D-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B472E-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4728-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4726-363D-11E5-9242-09173F13E4C5 n4:271B4729-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4727-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4736-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4737-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4731-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4732-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4734-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4733-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4735-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
856680-67-6
n3:Bioavailability
n4:271B473C-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B473E-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B473F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B473B-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B473A-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B473D-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B472B-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4738-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4739-363D-11E5-9242-09173F13E4C5